126 related articles for article (PubMed ID: 15998437)
1. Enhanced uptake of lactosaminated human albumin by rat hepatocarcinomas: implications for an improved chemotherapy of primary liver tumors.
Di Stefano G; Fiume L; Bolondi L; Lanza M; Pariali M; Chieco P
Liver Int; 2005 Aug; 25(4):854-60. PubMed ID: 15998437
[TBL] [Abstract][Full Text] [Related]
2. A conjugate of doxorubicin with lactosaminated albumin enhances the drug concentrations in all the forms of rat hepatocellular carcinomas independently of their differentiation grade.
Di Stefano G; Fiume L; Baglioni M; Bolondi L; Busi C; Chieco P; Kratz F; Manaresi F; Pariali M
Liver Int; 2006 Aug; 26(6):726-33. PubMed ID: 16842330
[TBL] [Abstract][Full Text] [Related]
3. Lactosaminated human albumin, a hepatotropic carrier of drugs.
Fiume L; Di Stefano G
Eur J Pharm Sci; 2010 Jul; 40(4):253-62. PubMed ID: 20403430
[TBL] [Abstract][Full Text] [Related]
4. Doxorubicin coupled to lactosaminated human albumin: a hepatocellular carcinoma targeted drug.
Fiume L; Baglioni M; Bolondi L; Farina C; Di Stefano G
Drug Discov Today; 2008 Nov; 13(21-22):1002-9. PubMed ID: 18755287
[TBL] [Abstract][Full Text] [Related]
5. Doxorubicin coupled to lactosaminated albumin inhibits the growth of hepatocellular carcinomas induced in rats by diethylnitrosamine.
Fiume L; Bolondi L; Busi C; Chieco P; Kratz F; Lanza M; Mattioli A; Di Stefano G
J Hepatol; 2005 Oct; 43(4):645-52. PubMed ID: 16023760
[TBL] [Abstract][Full Text] [Related]
6. Doxorubicin coupled to lactosaminated albumin: effect of heterogeneity in drug load on conjugate disposition and hepatocellular carcinoma uptake in rats.
Di Stefano G; Fiume L; Baglioni M; Busi C; Bolondi L; Farina C; Mori F; Chieco P; Pariali M; Kratz F; Molin L; Salmaso S; Caliceti P
Eur J Pharm Sci; 2008 Feb; 33(2):191-8. PubMed ID: 18201877
[TBL] [Abstract][Full Text] [Related]
7. Coupling of lactose molecules to the carrier protein hinders the spleen and bone marrow uptake of doxorubicin conjugated with human albumin.
Di Stefano G; Fiume L; Baglioni M; Busi C; Chieco P; Kratz F; Mattioli A
Eur J Pharm Sci; 2007 Feb; 30(2):136-42. PubMed ID: 17218086
[TBL] [Abstract][Full Text] [Related]
8. Liver-targeted doxorubicin: effects on rat regenerating hepatocytes.
Di Stefano G; Derenzini M; Kratz F; Lanza M; Fiume L
Liver Int; 2004 Jun; 24(3):246-52. PubMed ID: 15189276
[TBL] [Abstract][Full Text] [Related]
9. Conjugation of 5-fluoro-2'-deoxyuridine with lactosaminated poly-l-lysine to reduce extrahepatic toxicity in the treatment of hepatocarcinomas.
Di Stefano G; Busi C; Derenzini M; Trerè D; Fiume L
Ital J Gastroenterol Hepatol; 1998 Apr; 30(2):173-7. PubMed ID: 9675653
[TBL] [Abstract][Full Text] [Related]
10. The asialoglycoprotein receptor in human hepatocellular carcinomas: its expression on proliferating cells.
Trerè D; Fiume L; De Giorgi LB; Di Stefano G; Migaldi M; Derenzini M
Br J Cancer; 1999 Oct; 81(3):404-8. PubMed ID: 10507763
[TBL] [Abstract][Full Text] [Related]
11. Albumin-based drug carriers: comparison between serum albumins of different species on pharmacokinetics and tumor uptake of the conjugate.
Stehle G; Wunder A; Schrenk HH; Hartung G; Heene DL; Sinn H
Anticancer Drugs; 1999 Sep; 10(8):785-90. PubMed ID: 10573211
[TBL] [Abstract][Full Text] [Related]
12. Doxorubicin coupled to lactosaminated human albumin remains confined within mouse liver cells after the intracellular release from the carrier.
Di Stefano G; Kratz F; Lanza M; Fiume L
Dig Liver Dis; 2003 Jun; 35(6):428-33. PubMed ID: 12868680
[TBL] [Abstract][Full Text] [Related]
13. Coupling of the antiviral drug ara-AMP to lactosaminated albumin leads to specific uptake in rat and human hepatocytes.
Jansen RW; Kruijt JK; van Berkel TJ; Meijer DK
Hepatology; 1993 Jul; 18(1):146-52. PubMed ID: 7686877
[TBL] [Abstract][Full Text] [Related]
14. Doxorubicin coupled to lactosaminated albumin: Effects on rats with liver fibrosis and cirrhosis.
Di Stefano G; Fiume L; Domenicali M; Busi C; Chieco P; Kratz F; Lanza M; Mattioli A; Pariali M; Bernardi M
Dig Liver Dis; 2006 Jun; 38(6):404-8. PubMed ID: 16595196
[TBL] [Abstract][Full Text] [Related]
15. The enhancement of interstitial transport of a doxorubicin-lactosaminated albumin conjugate by imatinib: in rat hepatocellular carcinoma it is not preferentially higher than that in liver and bone marrow.
Fiume L; Baglioni M; Busi C; Manerba M; Di Stefano G
Eur J Pharm Biopharm; 2009 Aug; 72(3):630-1. PubMed ID: 19572414
[TBL] [Abstract][Full Text] [Related]
16. [Study on the hepatocytic cell targetability of liposomes].
Hou XP; Wang L; Wang XT; Li S
Yao Xue Xue Bao; 2003 Feb; 38(2):143-6. PubMed ID: 12778752
[TBL] [Abstract][Full Text] [Related]
17. Doxorubicin coupled to lactosaminated albumin: enhanced drug levels in rat hepatocarcinomas.
Di Stefano G; Busi C; Fiume L; Chieco P; Pariali M
Dig Liver Dis; 2006 Apr; 38(4):284-5. PubMed ID: 16364702
[No Abstract] [Full Text] [Related]
18. [Study on asialoglycoprotein receptor mediated endocytosis of antiviral conjugate].
Ju L; Huang-fu Y; Zhang L
Zhonghua Yi Xue Za Zhi; 1996 Feb; 76(2):124-7. PubMed ID: 8758445
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of doxorubicin coupled to lactosaminated albumin on rat hepatocellular carcinomas evaluated by ultrasound imaging.
Di Stefano G; Fiume L; Baglioni M; Bolondi L; Chieco P; Kratz F; Pariali M; Rubini G
Dig Liver Dis; 2008 Apr; 40(4):278-84. PubMed ID: 18054847
[TBL] [Abstract][Full Text] [Related]
20. The effect of ethanol on asialoglycoprotein receptor-mediated phagocytosis of apoptotic cells by rat hepatocytes.
McVicker BL; Tuma DJ; Kubik JA; Hindemith AM; Baldwin CR; Casey CA
Hepatology; 2002 Dec; 36(6):1478-87. PubMed ID: 12447874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
